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Introduction: Despite the frequent performance of minor foot amputations in patients with lower extremity vascular
disease, little is known regarding the rate of conversion to major amputations and the role of bypass graft timing in
relation to amputation.
Methods: Between January 1990 and December 2001, 670 patients underwent 920 minor amputations (interphalangeal,
ray, or transmetatarsal) on 747 limbs.
Results: Of 670 patients, 468 were men (69.9%), 616 had diabetes mellitus (91.9%), and 137 (19.7%) had a serum
creatinine level>2.0 mg/dL, of whom 92 were on dialysis (end-stage renal disease) (11.5%). Ipsilateral revascularization
was performed<30 days before the initial amputation in 64.9% (485 of 747), whereas 9.8% (73 of 747) had a bypass<30
days postamputation. The initial amputation levels were 466 interphalangeal (62.4%), 159 transmetatarsal (21.3%), and
122 ray (16.3%). Operative 30-day mortality was 0.7% (6 of 920). Limb salvage was 89.8% at 1 year and 82.3% at 5 years.
Diabetes mellitus had no impact on limb salvage (P  .61). Limb loss predictors included end-stage renal disease (odds
ratio [OR], 1.72, 95% confidence interval [CI], 1.12 to 2.83, P < .01) and the need for transmetatarsal amputation as
the initial procedure (OR, 1.62; 95% CI, 1.15 to 1.93; P< .01). Patients with revascularizations subsequent to an initial
amputation had a significant increase in limb loss (OR, 2.11; 95% CI, 1.39 to 4.21, P< .005). Patient survival was 83.9%
at 1 year and 43.5% at 5 years. Neither gender nor diabetes mellitus impacted survival; however, serum creatinine levels
>2.0mg/dL (5 years, 48.8% 2.3% vs 23.9% 4.2%, P< .0001) and the need for amajor amputation<30 days (3 years,
60.8%  2.1% vs 40.1%  7.8%, P < .01) adversely affected survival.
Conclusions: Although minor amputations can lead to limb preservation in most patients, the performance of a
revascularization subsequent to amputation, transmetatarsal as the initial amputation, and end-stage renal disease are
poor prognostic indicators. Inferior long-term patient survival is most closely associated with renal insufficiency and
conversion to major amputation early after the initial procedure. (J Vasc Surg 2005;42:476-80.)Hospital admissions in the United States for foot ulcer-
ation have been increasing over the past decade.1 Although
the absolute number of admissions is highest in nondiabetic
patients, the incidence is much greater among diabetic
patients, where foot ulcers are the most common cause for
hospitalization.2 A recent Veterans Health Administration
survey3 demonstrated that most nontraumatic lower ex-
tremity amputations were performed in diabetic patients
and most of these were minor foot amputations. Among
United States citizens with diabetes mellitus, 20% will be
hospitalized at least once for a foot problem,2 with a cost
exceeding $1 billion annually.2,4
In the past, toe gangrene was usually associated with
the need for a higher amputation level.5 As enthusiasm for
femoral-popliteal and then femoral-tibial arterial bypass for
limb salvage grew, the rates of limb loss correspondingly
decreased.6,7 Despite this evidence, amputations are still
performed in some areas without appropriate vascular in-
vestigations.8
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476The purpose of this study is to review a 12-year expe-
rience with lower extremity minor amputations and inves-
tigate which risk factors best predict patient survival and
limb loss. As diabetic and nondiabetic patients have been
shown to have similar healing rates after minor foot ampu-
tations,9,10 we have included both groups in this series. Our
hypothesis is that a carefully planned multidisciplinary ap-
proach to the treatment of foot ulcerations in patients with
peripheral vascular disease (PVD) can lead to excellent rates
of limb salvage regardless of glucose intolerance.
METHODS
Between January 1, 1990 andDecember 15, 2001, 670
patients with PVD underwent 920 minor amputations on
747 limbs at the Beth Israel Deaconess Medical Center.
Minor amputations were categorized as either interphalan-
geal, ray, or transmetatarsal. All patients with PVD under-
going these procedures during the study period were in-
cluded. PVDwas defined by the attending surgeon and was
generally considered present in any patient with a nonpal-
pable pedal pulse in the affected extremity. Patient data
were obtained retrospectively from our institution’s Vascu-
lar Surgery Registry, hospital medical records, and outpa-
tient office charts.
Seventy-two data points were entered for each patient,
including individual risk factors, procedural information,
and postoperative outcome. Of note, patients were pro-
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ciency if their preoperative serum creatinine level was2.0
mg/dL.
The operations were performed by one of eight vascular
surgery attendings supervising a surgical resident or vascu-
lar fellow. In general, each patient’s vascular status was
determined by a combination of physical exam and nonin-
vasive testing, according to the surgeon’s preference. An-
giograms were obtained in those deemed to require a
revascularization. Planned bypass procedures were either
done concurrently or 2 to 3 days of the amputation.
Combined bypass and amputation procedures were
usually performed under general anesthesia, and local or
regional anesthetic block was generally used for solitary
minor amputations. Spinal or epidural anesthesia was less
common.
All patients undergoing a bypass were observed in a
step-down intensive care unit for at least 24 hours. Glucose
control for all diabetic patients wasmonitored by physicians
from the Joslin Diabetes Center.
Patient follow-up included routine office visits supple-
mented with telephone interviews when required. The
average length of follow-up was 47.3 months (range, 1 to
158). Dates of death were confirmed with the online Social
Security Death Index (http://www.ancestry.com/search/
rectype/vital/ssdi/main.htm).
Statistics were performed with the aid of Statview 5.0
software (SAS Institute Inc, Cary, NC). Categoric variables
were compared with Fischer’s exact test or 2 test as appro-
priate. Continuous variables were evaluated with Student’s
t test. Factors found to be significant in univariate analysis
were then studied in multivariate logistic regression. Inde-
pendent variables were assumed to be significant if theWald
test returned a P value of .05 and the 95% confidence
interval of the odds ratio did not contain the integer 1.
Survival rates were calculated using the Kaplan-Meier prod-
uct-limit method. The Mantel-Cox log-rank test was used
to compare survival curves among different groups, with
significant differences assumed at P  .05. Data reporting
and analyses were performed in accordance with the recom-
mendations of Rutherford et al.11
RESULTS
Of the 670 patients in the study, 468 (69.9%) were
male, 616 (91.9%) had diabetes mellitus, 74 (11%) actively
used tobacco, 63 (9.4%) had quit tobacco  2 years, 435
(64.9%) had hypertension, 480 (71.6%) were diagnosed
with coronary artery disease (CAD), 137 (19.7%) had renal
insufficiency, and 92 (11.5%) were dialysis dependent (end-
stage renal disease).
For the 747 limbs, initial amputation levels were 466
(62.4%) interphalangeal, 159 (21.3%) transmetatarsal, and
122 (16.3%) ray. An initial ray-level amputation was more
likely in patients with diabetes mellitus (119 of 690, 17.2%
vs 3 of 57, 5.3%; P  .05). The incidence of initial trans-
metatarsal level amputation was statistically similar for dia-
betic and nondiabetic patients (146 of 690, 21.2% vs 13 of
57, 22.8%; P  .62).An arterial bypass procedure was performed 30 days
before or concurrent with the minor amputation in 485
(64.9%) limbs. A subsequent bypass was performed 30
days of the initial amputation in 73 (9.8%) limbs. The
indications for delayed bypass were active infection (35 of
73, 47.9%), surgeon preference (12 of 73, 16.4%), and
nonhealing of the minor amputation (26 of 73, 35.6%). Of
the 26 cases that required a delayed bypass for nonhealing,
21 occurred during the first half of the study (1990 to
1995), and five were during the latter half (1996 to 2001).
The 30-day operative mortality for all of the minor
amputations performed was 0.6% (6 of 920). Diabetes
mellitus (P  .71), end-stage renal disease (P  .38), level
of amputation (P .83), type of anesthesia (P .41), and
timing of revascularization (P  .73) had no significant
association with operative mortality.
On a per-limb basis, 2.9% (22 of 747) required a
conversion to major amputation 30 days of the initial
surgery. Overall limb salvage was 89.8%  1.1% at 1 year
and 82.3%  3.4% at 5 years. The salvage rates were nearly
identical in the diabetic and nondiabetic groups (5 years,
82.2% 1.8% vs 83.5% 5.5%, P .72). Both renal failure
(Fig 1) and the need for an initial amputation at the
transmetatarsal level (Fig 2) were associated with increased
limb loss.
Patients who received a delayed bypass after the initial
minor amputation were found to have diminished limb
salvage (1 year, 77.4% 3.1% vs 90.2% 1.2%, P .001).
Subgroup analysis of these cases revealed a significant asso-
ciation with limb loss, regardless of whether the delay was
because of infection (1 year, 79.5%  4.6% vs 90.8% 
1.2%, P  .01), surgeon preference (1 year, 71.9%  7.8%
vs 90.2%  1.2%, P  .05), or poor healing of the minor
amputation (1 year, 74.1%  5.9% vs 91.1%  1.1%, P 
.05). Multivariate logistic regression analysis of all risk
factors found to have an association with reduced limb
salvage was performed. The three variables found to inde-
Fig 1. Kaplan-Meier survival curves demonstrating limb salvage
in patients with and without end-stage renal disease (ESRD).
Standard error is 10% in the displayed series. Solid line, nonure-
mic; dashed line, ESRD (P  .005).pendently predict limb loss are listed in the Table.
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Kaplan-Meier analysis. Freedom from contralateral ampu-
tation (major or minor) was 93.2%  0.9% at 1 year. The
presence of renal insufficiency was associated with an in-
creased risk of any contralateral amputation at 1 year
(14.6%  3.3% vs 4.2%  0.9%, P  .01).
Patient survival was 83.9%  1.4% at 1 year and 43.5%
 2.1% at 5 years. Survival was not affected by gender (P
.46), diabetes mellitus (P  .84), or initial minor amputa-
tion level (P  .67). Adverse survival was associated with
renal insufficiency (5 years, 48.8% 2.3% vs 23.9% 4.2%,
P  .0001) (Fig 3) and conversion to major amputation
30 days (3 years, 60.8%  2.1% vs 40.1%  7.8%, P 
.01) (Fig 4).
DISCUSSION
The transmetatarsal amputation was developed by Le-
land McKittrick12 in 1949 for the treatment of forefoot
gangrene in patients with diabetes mellitus. As the previous
standard therapy was major amputation, this development
was responsible for saving thousands of limbs. Detractors
Fig 2. Kaplan-Meier survival curves showing limb salvage for all
patients as a function of their initial amputation level. Salvage was
significantly lower in the transmetatarsal group when compared
with either the interphalangeal or ray group (P.05). Standard
error is 10% in the displayed series. Solid line, ray; dashed line,
interphalangeal; dotted line, transmetatarsal.
Table I. Independent predictors of limb loss as
determined by logistic regression analysis
Risk factor Wald test OR 95% CI
ESRD P  .01 1.72 1.12-2.83
TMA* P  .01 1.62 1.15-1.93
Subsequent bypass† P  .005 2.11 1.39-4.21
OR, Odds ratio; CI, confidence interval; ESRD, end-stage renal disease;
TMA, transmetatarsal.
*Indicates a transmetatarsal level as the initial amputation on that limb.
†Refers to a revascularization performed after the minor amputation, 30
days.have pointed out that it is more successful when used forinfection than ischemia,13 and others have shown high rates
of early limb loss.14 Still, when combined with arterial
bypass, transmetatarsal amputation can yield excellent rates
of limb salvage.15-18 In our series, although the need for a
transmetatarsal as the initial amputation level predicted an
increased likelihood of limb loss, the overall salvage rate for
this procedure was still 78%  3.8% at 5 years.
Improved limb salvage in patients with both diabetes
mellitus and PVD has followed better understanding of the
underlying disease process. In the past, tissue loss in this
group was ascribed to microvascular arterial obliteration,19
or “small vessel disease,” resulting in a powerless feeling in
the treating physician and the reliance upon primary ampu-
Fig 3. Kaplan-Meier analysis of patient survival as a function of
renal insufficiency (serum creatinine level2.0 mg/dL). Standard
error is 10% in the displayed series. Solid line, serum creatinine
2.0 mg/dL; dashed line, serum creatinine 2.0 mg/dL (P 
.000).
Fig 4. Kaplan-Meier analysis demonstrating survival for all indi-
viduals in the series. Patients have been divided into two groups
representing those who required a major ipsilateral amputation
30 days of their initial minor amputation and those who did not.
Standard error is 10% in the displayed series. Solid line, no early
major amputation; dashed line, early major amputation (P  .01).tations. Clearly, we now understand the process to be the
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vessels.20-24 Through more aggressive use of tibial bypass,
limb preservation has improved greatly.7
When looking at the general population, diabetes mel-
litus is an independent risk factor for PVD.25 Among the
diabetic population, PVD has been found to be predictive
of both foot ulceration26-28 and amputation.29-31 In our
series, the main difference between diabetic and nondia-
betic patients was the higher incidence of ray amputations
in those with diabetes mellitus, whereas the transmetatarsal
rates were remarkably similar.
Comparing diabetic with nondiabetic patients in the
face of tissue loss with associated PVD, therefore, we can
see many similar behaviors. Our study demonstrated no
significant difference in either the long-term survival or
limb salvage rates among these groups. Although our rela-
tively small number of nondiabetic patients may suggest the
possibility of a type II error, other series have corroborated
these findings demonstrating statistically similar healing
rates of both toe9 and transmetatarsal10 amputations in the
two groups. These results seem to show that nondiabetic
patients may behave in a “diabetic” fashion once their PVD
results in necrosis that requires amputation.
As the judicious use of arterial bypass results in im-
proved healing of minor amputations,9,32,33 the reliable
prediction of healing ability is an integral part of the treat-
ment plan for forefoot ischemia. Indeed, as this series
demonstrates, any deferment of necessary revascularization
after minor foot amputation is predictive of treatment
failure and limb loss. Therefore, the surgeon should make
every effort to prevent avoidable causes of delayed bypass.
Noninvasive laboratory studies such as transcutaneous PO2
34-36 and segmental toe pressures37,38have correlated well
with healing levels in some studies. Our bias, however, is
that these investigations provide no clinical outcome im-
provement for experienced vascular surgeons in the setting
of tissue loss. In light of this, over the course of this series,
we have developed an aggressive protocol for dealing with
forefoot gangrene in the face of PVD:
1. Prompt and complete surgical drainage of any underly-
ing infection. Débridement of uninfected necrotic tissue
is not performed as an initial procedure.
2. Institution of broad-spectrum antibiotics until bacteri-
ology is detrmined.
3. Evaluation for peripheral ischemia. If a clearly palpable
dorsalis pedis or posterior tibial artery pulse is not
present, angiography is performed.
4. Intra-arterial digital subtraction arteriography is ob-
tained with anterior-posterior and lateral views of the
involved foot.
5. Arterial bypass is then performed to the most proximal
vessel in the leg that will yield a palpable pulse in the
foot. Often, this most “proximal” vessel is the dorsalis
pedis.
6. Final débridement, amputation, and wound closure can
then be accomplished under conditions of optimal per-fusion. This is usually performed during the same visit to
the operative suite.
Anecdotally, as we have become increasingly adherent
to this protocol, our frequency of delayed revasculariza-
tions for poor amputation site healing has been reduced
from 21 during the first half of this series to 5 during the
latter 6 years. Some causes of delayed bypass remain un-
avoidable, but we believe that an aggressive approach to
revascularization will help to minimize the limb loss asso-
ciated with a “backed into” bypass and the adverse survival
seen with an early conversion to major amputation. Al-
though the care of patients with forefoot necrosis and PVD
can be extremely challenging, excellent rates of limb salvage
may be achieved through this method and the lifelong care
of the patient with a multidisciplinary team including car-
diologists, podiatrists, endocrinologists, and rehabilitation
specialists.
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